LEGISLATIVE BUDGET BOARD Austin, Texas FISCAL NOTE, 85TH LEGISLATIVE REGULAR SESSION Revision 1 March 6, 2017 TO: Honorable Four Price, Chair, House Committee on Public Health FROM: Ursula Parks, Director, Legislative Budget Board IN RE:HB1067 by Meyer (Relating to newborn screening tests for adrenoleukodystrophy.), As Introduced No significant fiscal implication to the State is anticipated. The bill would amend the Health and Safety Code relating to newborn screening tests for adrenoleukodystrophy (ALD). Health and Safety Code Chapter 33 currently requires the Department of State Health Services (DSHS) to screen for disorders listed as core and secondary conditions in the Recommended Uniform Screening Panel of the Secretary's Advisory Committee on Heritable Disorders in Newborns and Children, to the extent funding is available. ALD is listed among core conditions in the Recommended Uniform Screening Panel, however DSHS does not currently screen for ALD. The bill would not add a new requirement to DSHS, therefore it is assumed this bill would have no significant fiscal impact. The bill would be effective September 1, 2017. Local Government Impact According to the Texas Association of Counties the fiscal impact to counties cannot be determined. Source Agencies:529 Health and Human Services Commission, 537 State Health Services, Department of LBB Staff: UP, KCA, EP, RD, SD, JGA
LEGISLATIVE BUDGET BOARD
Austin, Texas
FISCAL NOTE, 85TH LEGISLATIVE REGULAR SESSION
Revision 1
March 6, 2017
Revision 1
Revision 1
TO: Honorable Four Price, Chair, House Committee on Public Health FROM: Ursula Parks, Director, Legislative Budget Board IN RE:HB1067 by Meyer (Relating to newborn screening tests for adrenoleukodystrophy.), As Introduced
TO: Honorable Four Price, Chair, House Committee on Public Health
FROM: Ursula Parks, Director, Legislative Budget Board
IN RE: HB1067 by Meyer (Relating to newborn screening tests for adrenoleukodystrophy.), As Introduced
Honorable Four Price, Chair, House Committee on Public Health
Honorable Four Price, Chair, House Committee on Public Health
Ursula Parks, Director, Legislative Budget Board
Ursula Parks, Director, Legislative Budget Board
HB1067 by Meyer (Relating to newborn screening tests for adrenoleukodystrophy.), As Introduced
HB1067 by Meyer (Relating to newborn screening tests for adrenoleukodystrophy.), As Introduced
No significant fiscal implication to the State is anticipated.
No significant fiscal implication to the State is anticipated.
The bill would amend the Health and Safety Code relating to newborn screening tests for adrenoleukodystrophy (ALD). Health and Safety Code Chapter 33 currently requires the Department of State Health Services (DSHS) to screen for disorders listed as core and secondary conditions in the Recommended Uniform Screening Panel of the Secretary's Advisory Committee on Heritable Disorders in Newborns and Children, to the extent funding is available. ALD is listed among core conditions in the Recommended Uniform Screening Panel, however DSHS does not currently screen for ALD. The bill would not add a new requirement to DSHS, therefore it is assumed this bill would have no significant fiscal impact. The bill would be effective September 1, 2017.
Local Government Impact
According to the Texas Association of Counties the fiscal impact to counties cannot be determined.
Source Agencies: 529 Health and Human Services Commission, 537 State Health Services, Department of
529 Health and Human Services Commission, 537 State Health Services, Department of
LBB Staff: UP, KCA, EP, RD, SD, JGA
UP, KCA, EP, RD, SD, JGA